N6-Methyladenosine RNA Methylation Regulator-Related Alternative Splicing (AS) Gene Signature Predicts Non–Small Cell Lung Cancer Prognosis

N6-Methyladenosine RNA Methylation Regulator-Related Alternative Splicing (AS) Gene Signature Predicts Non–Small Cell Lung Cancer Prognosis

Aberrant N6-methyladenosine (m6A) RNA methylation regulatory genes and related gene alternative splicing (AS) could be used to predict the prognosis of non–small cell lung carcinoma. This study focused on 13 m6A regulatory genes (METTL3, METTL14, WTAP, KIAA1429, RBM15, ZC3H13, YTHDC1, YTHDC2, YTHDF1...

Full description

Bibliographic Details
Main Authors: Zhenyu Zhao, Qidong Cai, Pengfei Zhang, Boxue He, Xiong Peng, Guangxu Tu, Weilin Peng, Li Wang, Fenglei Yu, Xiang Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-06-01
Series:Frontiers in Molecular Biosciences
Subjects:
non–small cell lung cancer
m6A
alternative splicing
The Cancer Genome Atlas
prognostic signature
Online Access:https://www.frontiersin.org/articles/10.3389/fmolb.2021.657087/full

Internet

https://www.frontiersin.org/articles/10.3389/fmolb.2021.657087/full

Similar Items